PLRXPliant Therapeutics, Inc.

$82M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$57M

Gross Profit

$57M100.0% margin

Operating Income

-$1M-2.2% margin

Net Income

-$631,000-1.1% margin

EPS (Diluted)

$0.01

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$119M

Total Liabilities

$119M

Stockholders' Equity

-$435,000

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$0	—
Gross Profit	$57M	-$666,000	+8666.4%
Operating Income	-$1M	-$31M	+96.0%
Net Income	-$631,000	-$30M	+97.9%

PLRX FY 2019 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena